Comprehensive Metabolic Panel (CMP): Nursing Guide
A CMP reports 14 chemistry results in one venous draw — the eight BMP analytes plus albumin, total protein, ALP, ALT, AST, and bilirubin — giving nurses a wider kidney, liver, and metabolic snapshot. The main safety story is reading the whole panel together: do not fixate on one normal liver enzyme while potassium is critical, confirm fasting when ordered, and escalate institution-defined critical chemistry values with symptoms and medicine trends.
Contents
Quick Facts
Key Takeaway
A CMP is broader than a BMP: it adds liver enzymes, bilirubin, and proteins to the same electrolyte, glucose, calcium, and renal markers nurses already trend.
Specimen & Collection Details
Nurse quick-reference for collection prep that affects result quality.
Serum or plasma separator tube per local protocol
Tube type and additive vary by laboratory — verify institutional phlebotomy policy
Serum or plasma (venous blood)
Typically one venous sample for full panel — volume per phlebotomy protocol
Often morning draw when fasting is required; stat timing for acute illness per order
fasting (no food or drink) for eight hours may be required — confirm with ordering clinician and laboratory instructions
Label promptly at bedside; transport per laboratory policy; avoid hemolysis and prolonged delay before processing
Not specified in reviewed references — many hospitals report chemistry within hours; follow local laboratory policy
Clinical chemistry / comprehensive metabolic panel (Chem 14)
What is Comprehensive Metabolic Panel (CMP)?
Comprehensive Metabolic Panel (CMP) is a routine venous blood test that measures 14 substances in one sample. standard clinical references lists glucose; calcium; electrolytes (sodium, potassium, bicarbonate, and chloride); albumin and total protein; liver enzymes (ALP, ALT, and AST); bilirubin; and kidney waste products (BUN and creatinine). It provides information about metabolism, fluid and electrolyte balance, liver and kidney health, and protein levels. It is also called chem 14, chemistry panel, chemistry screen, or metabolic panel.
Overview
Nurses use CMP results across acute care, clinics, and preoperative pathways to evaluate nausea, confusion, medicine effects, and chronic conditions such as nonalcoholic fatty liver disease or hepatitis C. The panel is broader than a basic metabolic panel (BMP) and often triggers additional testing rather than a final diagnosis.
providers compare all CMP results with health history and medicines — nurses should avoid treating one normal line as proof the entire panel is benign, especially when hepatotoxic drugs, poor intake, oliguria, or acute acute kidney injury patterns are suspected.
Before collection: verify CMP vs BMP order, fasting instructions, IV fluid status, and medicines (diuretics, ACE inhibitors/ARBs, insulin, statins, acetaminophen, antibiotics). After results: trend creatinine, potassium, ALT/AST, and bilirubin with prior values; assess weakness, nausea, urine output, and mental status; execute critical-value notification and read-back per policy.
Electrolyte, Liver Enzyme, and Critical-Value CMP Safety
A CMP is ordered so often that nurses may skim past critical potassium while debating a mild glucose elevation — or focus on liver enzymes while missing oliguria and rising creatinine. One normal CMP line does not clear the other 13. Always compare to prior CMP values, hepatotoxic medicines, and institution-defined critical limits.
- Critical hyperkalemia with weakness, cramping, ECG changes, or hypotension
- Sharp ALT/AST or bilirubin rise with nausea, jaundice, or acetaminophen/hepatotoxic exposure
- Rapid creatinine rise with decreased urine output while on nephrotoxic or diuretic therapy
- Reassuring the team based on one normal CMP component while others are critical or trending badly
Document: each abnormal component with reference interval, trend vs prior CMP, fasting status, medicines and IV fluids, intake/output, prescriber notification, ECG or repeat labs ordered, and patient teaching on report-now symptoms including jaundice and oliguria.
Hyperkalemia escalation (follow institutional critical-value policy)
- Stop IV potassium and hold potassium-sparing medicines per prescriber or protocol
- Obtain 12-lead ECG when K⁺ is at or above institutional critical threshold or the patient has weakness, cramping, or palpitations
- Notify prescriber with closed-loop read-back; document time, value, and symptoms
- Implement ordered treatment and repeat CMP or focused electrolytes per protocol
What a CMP Can and Cannot Tell You
This test can help identify:
- Electrolyte and acid-base disturbances (sodium, potassium, chloride, CO₂)
- Kidney function trends via BUN and creatinine (standard clinical references)
- Hepatocellular or cholestatic patterns via ALT, AST, ALP, and bilirubin
- Protein and albumin status suggesting liver synthetic function or malnutrition
- Hyperglycemia context when glucose is interpreted with fasting status
This test cannot:
- Diagnose a specific disease by itself — confirmatory testing is usually required
- Localize liver disease cause (viral, alcoholic, drug-induced) without additional serology or imaging
- Replace hemodynamic assessment, ECG, or urine output monitoring for electrolyte emergencies
- Rule out acute kidney or liver injury when values are still near baseline early in the course
Pre-draw Checks for CMP Chemistry
Verify
Clarify before proceeding when:
- Order unclear (CMP vs BMP vs isolated chemistry)
- Fasting status conflicts with patient report or MAR
- Patient on hepatotoxic medicines with new nausea but only BMP ordered — clarify panel scope
- Prior hemolyzed specimen — confirm repeat technique to protect potassium accuracy
- Active jaundice, oliguria, or weakness before routine outpatient draw — assess acuity first
- Critical CMP result pending without prescriber acknowledgment
- Result conflicts with presentation (very ill patient with “normal” CMP yesterday only)
Reading CMP Liver, Renal, and Electrolyte Patterns Together
Integrate all 14 analytes with intake/output, blood pressure, medicines, and serial trends. official endocrine references notes kidney and liver evaluation usually requires history, examination, and additional testing — CMP is a screening snapshot across multiple organ systems.
| Clinical context | Pair on CMP | Nursing focus |
|---|---|---|
| Hepatotoxic medicine exposure | Rising ALT/AST with bilirubin | Notify prescriber; review acetaminophen dose and hold orders; monitor nausea and jaundice |
| Diuretic or ACE inhibitor therapy | Rising creatinine with hyperkalemia or hyponatremia | Medicine review; monitor urine output and BP; escalate per policy |
| Oliguria with azotemia | BUN and creatinine rise with low urine output | Assess perfusion, hold nephrotoxins per order, coordinate repeat CMP trend |
| Glucose surveillance | Glucose with fasting status documented | Confirm fasting; coordinate diabetes team follow-up as ordered |
| Acid-base question | Low CO₂ with potassium and creatinine | Consider ABG or bicarbonate trend; assess respiration and perfusion |
Hepatocellular vs cholestatic hints on CMP
ALT and AST elevations with bilirubin may suggest hepatocellular injury; disproportionate ALP rise may suggest cholestasis — always interpret with symptoms, medicines, and prior CMP trends. Low albumin with rising bilirubin may reflect reduced synthetic function; pair with clinical assessment and prescriber-directed follow-up.
CMP Trends and Collection Traps at the Bedside
| Bedside point | Nursing note |
|---|---|
| Whole-panel read | Do not close the chart after a normal glucose — scan potassium, creatinine, and LFTs on the same CMP |
| Hemolysis trap | Reject or repeat hemolyzed tubes — falsely high potassium can trigger unnecessary emergency treatment |
| Fasting confusion | several-hour fast — match MAR, patient report, and lab requisition |
| Medicine link | Pair rising ALT with acetaminophen, statins, and antibiotics on the MAR the same shift |
| Panel literacy | Chart each abnormal component with value — avoid “CMP abnormal” without specifics |
| Jaundice cue | New scleral icterus with elevated bilirubin on CMP warrants same-day prescriber review |
CMP in Acute and Routine Care Workflow
Diagnostic safety badge: Critical-result test — prompt review and escalation may be required when institution-defined chemistry critical values, acute LFT rise, or clinical deterioration are present.
Check-before-test protocol
- Identity + CMP order + fasting status
- Medicine, IV fluid, and intake/output review
- Prior CMP trend reviewed (renal and hepatic lines)
- Phlebotomy tube and label verified
- Symptom red flags assessed before discharge from unit or clinic
Critical teach-back questions
- “Can you tell me why we are checking your kidney, liver, and electrolyte blood tests today?”
- “Which symptoms — like nausea, yellowing skin or eyes, weakness, or decreased urination — should you report right away?”
- “What fasting instructions did your team give you before this blood draw?”
Care coordination: primary prescriber, hepatology, nephrology, pharmacy, laboratory, diabetes team, and rapid response per institutional protocol when critical CMP values, acute LFT rise, or AKI are suspected.
CMP Quick Safety Checklist
- Was fasting required and actually achieved for this CMP?
- What did the last potassium, creatinine, and ALT look like compared with today?
- Which hepatotoxic or nephrotoxic medicines could explain this pattern?
- Do symptoms, jaundice, blood pressure, and urine output match the numbers?
- Who must be notified now if a critical value, LFT spike, or AKI trend is present?
Why Comprehensive Metabolic Panel (CMP) is Ordered
A CMP is ordered when clinicians need a broader metabolic, hepatic, renal, and electrolyte overview — for routine screening, acute evaluation, or treatment monitoring.
| Clinical Indication | What the Test Answers | Nursing Rationale |
|---|---|---|
| Routine checkup or preoperative assessment | Is there baseline evidence of kidney, liver, electrolyte, or glucose abnormality? | standard clinical references lists routine health screening as a common CMP use to find problems before symptoms appear. |
| Signs or symptoms suggesting liver, kidney, or metabolic disease | Do CMP patterns explain fatigue, nausea, jaundice, or confusion? | Supports evaluation of hepatic injury, renal dysfunction, electrolyte disturbance, or hyperglycemia in symptomatic patients. |
| Monitoring medicines that affect liver or kidneys | Is treatment causing hepatotoxicity or nephrotoxicity? | CMP may check whether treatment is working and/or causing side effects on liver or kidneys. |
| Follow-up after prior abnormal CMP or chronic disease surveillance | Are liver enzymes, proteins, creatinine, and electrolytes stable on therapy? | Trending CMP components guides medicine adjustment and additional testing per prescriber plan. |
Contraindications and Precautions
Venous CMP collection has few true contraindications. Nursing focus is safe phlebotomy, correct fasting communication, and timely escalation of dangerous chemistry results across all 14 analytes.
- Institution-defined critical potassium, glucose, sodium, calcium, or creatinine values — execute critical-value protocol per policy.
- Sharp rise in ALT, AST, or bilirubin with nausea, jaundice, coagulopathy signs, or hepatotoxic medicine exposure.
- CMP markedly abnormal while patient receives nephrotoxic, hepatotoxic, or electrolyte-altering medicines without prescriber review.
- Hemolyzed specimens may falsely elevate potassium — recollect per laboratory guidance.
- Non-fasting sample when fasting CMP was ordered may affect glucose interpretation.
- Single normal CMP line does not clear the panel — rising liver enzymes with stable creatinine still needs follow-up.
- Critical or markedly abnormal potassium with weakness, cramping, or ECG changes
- Acute hepatocellular pattern (rising ALT/AST and bilirubin) with vomiting or jaundice
- Creatinine rising sharply from baseline with decreased urine output or hypotension
Patient Preparation
Preparation depends on whether fasting is ordered. you may need to fast for several hours before the test — confirm with the ordering clinician and laboratory.
Pre-test checksReview diuretics, ACE inhibitors, ARBs, potassium supplements, insulin and oral hypoglycemics, NSAIDs, statins, acetaminophen, and other hepatotoxic or nephrotoxic medicines. Standard clinical references advise patients not to stop medicines before testing unless the provider instructs them to. Nurses communicate CMP abnormalities that may relate to current therapy to the prescriber.
Performance — nursing procedure guide
This page is a Tests & Diagnostics guide for Comprehensive Metabolic Panel (CMP). It emphasizes why the test is ordered, how to interpret results, when to escalate, and preparation factors that affect validity — not step-by-step performance technique (those live under Nursing Procedures when available).
Step-by-step technique, supplies, infection prevention, and immediate post-procedure monitoring for this test are covered in:
Use the Patient preparation, Results and interpretation, and Nursing responsibilities sections on this page for order verification, pre-analytic checks, result follow-up, critical-value escalation, and documentation.
Result follow-up at a glance
Nursing workflow on this page — from order to safe action on results:
Results and Interpretation
Each CMP component is reported with the laboratory’s reference interval. Compare results to prior values, intake/output, medicines, and symptoms — not to memorized universal numbers.
Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.
| Result | Range / Finding | Clinical Meaning | Nursing Action |
|---|---|---|---|
| Within reference interval | Institution- and laboratory-specific — not specified as one universal numeric range in reviewed clinical references | Components within reporting reference intervals for this laboratory | Continue routine monitoring per indication; reassess if symptoms or medicines suggest risk despite normal values |
| Borderline / near reference limit | One or more components just outside reference interval or changed from prior baseline | May reflect early dehydration, medicine effect, or evolving renal change — interpret with trend and clinical context | Notify prescriber per protocol; schedule repeat BMP or expanded testing as ordered |
| High / above reference interval | Above institutional upper reference limit (e.g., potassium, glucose, BUN, creatinine) | May indicate hyperkalemia, hyperglycemia, azotemia, hepatocellular injury, or other metabolic or hepatic disturbance — requires clinical correlation | Assess symptoms and ECG when potassium is high; notify prescriber; implement critical-value protocol when defined locally |
| Low / below reference interval | Below institutional lower reference limit (e.g., sodium, potassium, glucose, calcium) | May reflect dehydration, diuretic effect, poor intake, or hypoglycemia depending on component — requires urgent assessment when symptomatic | Assess neurologic and cardiovascular status; notify prescriber; treat symptomatic hypoglycemia per protocol |
Critical CMP Results and Escalation
Universal numeric critical CMP thresholds are Turnaround and screening rules vary by institution; follow local institutional policy. Many institutions define chemistry critical values locally for potassium, glucose, sodium, calcium, creatinine, and sometimes liver enzymes or bilirubin. Escalate when results meet local critical limits or when the patient is symptomatic or deteriorating.
| Critical Finding | Threshold / Value | Immediate Action |
|---|---|---|
| Critical hyperkalemia or rapid potassium rise | Institution-defined critical potassium and/or muscle weakness, cramping, or ECG changes | Critical-value notification, prescriber escalation, cardiac monitoring per protocol |
| Critical glucose abnormality | Institution-defined critical high or low glucose with or without symptoms | Treat symptomatic hypoglycemia per protocol; notify prescriber for severe hyperglycemia |
| Acute hepatocellular injury pattern on CMP | Sharp rise in ALT/AST and bilirubin with nausea, jaundice, or hepatotoxic exposure | Escalate according to facility policy; review medicines, hold hepatotoxins per order, coordinate repeat CMP and additional liver testing |
Escalate according to facility policy and the patient’s clinical condition when CMP results meet critical limits, conflict with stability, or accompany weakness, jaundice, arrhythmia, oliguria, or altered mental status.
Factors Affecting Results
CMP interpretation depends on laboratory method, specimen quality, fasting status, medicines, hydration, and whether liver or renal trends are read together.
- Falsely elevated potassium from hemolyzed specimen
- Mild BUN elevation from high protein meal or GI bleeding without renal failure
- Non-fasting glucose elevation that does not reflect chronic diabetes control
- Normal creatinine early in acute kidney injury — trend and urine output still matter
- Normal potassium while total body potassium is depleted in some clinical states
- Normal ALT while AST, bilirubin, or creatinine are rising — panel must be read as a whole
- Hemolysis, delayed processing, or incorrect tube
- IV fluids, diuretics, potassium supplements, insulin, and nephrotoxic drugs
- Non-fasting state, dehydration, age, and muscle mass (creatinine context)
abnormal CMP results may suggest several conditions but usually require more tests to confirm a diagnosis. CMP does not replace imaging, biopsy, or disease-specific serology when liver or kidney disease is suspected.
Nursing Responsibilities
Nursing care spans safe phlebotomy, medicine and fluid review, integrated panel interpretation, critical-value escalation, and patient teaching.
Before the TestDocumentation
Clear documentation supports continuity when CMP trends during hepatotoxic medicine therapy, AKI workup, or diabetes management.
“CMP at 0740 fasting: K+ 5.9 mmol/L (critical), ALT 420 U/L (H), AST 380 U/L (H), total bilirubin 4.2 mg/dL (H), Cr 2.1 mg/dL (H). Prior CMP one week ago with normal LFTs. Patient reports nausea and decreased urine output. Acetaminophen and lisinopril on MAR. Dr. Chen notified 0745 with critical-value read-back; ECG ordered. Patient taught to report worsening nausea, jaundice, weakness, or decreased urination.”
- Indication, fasting status, and IV fluid status at draw time
- Each abnormal CMP component with reference interval and trend
- Symptoms, urine output, and relevant medicines reviewed
- Critical-value read-back and prescriber notification
- Interventions initiated (ECG, repeat labs, hold orders) per protocol
- Patient teaching and pending repeat-test plan
Patient and Family Education
Use plain language while emphasizing the CMP checks kidney, liver, protein, electrolyte, and blood sugar status in one blood draw.
Comprehensive Metabolic Panel (CMP) NCLEX practice questions
Practice NCLEX-style clinical judgment focused on Comprehensive Metabolic Panel (CMP) safety and nursing judgment. Use the case tabs (orders, results, assessment, nursing notes), then answer eight Next Gen–style items (including an ordered workflow step) and evaluate outcomes with the answer key.
Select a tab to view orders, results, assessment, and nursing note details for this case.
- Order: CMP — acute medical unit
- Indication: Nausea, weakness, and hepatotoxic medicine exposure; monitor liver, kidney, and electrolytes
- Timing: Fasting CMP collected 0740; prior CMP one week ago with normal LFTs
- Related orders: CMP stat; repeat CMP in 12 hours; ECG; strict intake and output
- Result: K+ 5.9 mmol/L (critical), ALT 420 U/L (H), AST 380 U/L (H), total bilirubin 4.2 mg/dL (H), Cr 2.1 mg/dL (H), albumin 2.8 g/dL (L)
- Trend / prior value: LFTs normal one week ago; potassium critical vs prior 4.3 mmol/L; creatinine up from 1.0 mg/dL
- Pending tests: Hepatitis serology ordered — not yet resulted
- Vital signs: T 37.1°C, HR 98/min, BP 94/60 mmHg, RR 18/min, SpO₂ 97% on room air
- Symptoms: Reports nausea, weakness, and decreased urine since yesterday; scleral icterus noted; denies chest pain
- Focused assessment: Dry mucous membranes; lethargic but oriented ×3; mild right upper quadrant tenderness
- Preparation notes: Fasting confirmed; high-dose acetaminophen and lisinopril on MAR; oral intake poor ×3 days
- Collection events: Specimen collected without hemolysis; labeled at bedside
- Teaching gaps / safety concerns: Critical hyperkalemia with acute hepatocellular rise and AKI pattern on same CMP
Answer key & rationale
Frequently Asked Questions
FAQ
What does a CMP measure?
standard clinical references lists 14 substances: glucose, calcium, electrolytes (sodium, potassium, bicarbonate, chloride), albumin, total protein, liver enzymes (ALP, ALT, AST), bilirubin, BUN, and creatinine — providing information about metabolism, fluid balance, liver and kidney health, and protein levels.
Does the patient need to fast before a CMP?
you may need to fast for several hours before the test. Nurses should confirm fasting requirements on each order because local practice may vary.
What does an abnormal CMP mean?
Abnormal results may suggest liver or kidney disease, diabetes, electrolyte problems, or other conditions, but more tests are usually needed to confirm a specific diagnosis.
How is a CMP different from a BMP?
In practice, a BMP includes eight of the 14 CMP tests. A CMP adds total protein, albumin, bilirubin, and liver enzymes (ALP, ALT, AST) when broader hepatic and protein assessment is needed.
When should nurses escalate CMP results?
Escalate when institution-defined critical values are reported, when potassium or creatinine trends worsen with symptoms, when ALT/AST or bilirubin rise sharply, or when results conflict with clinical stability — according to facility policy.
Can a CMP diagnose liver disease or kidney failure alone?
No. Elevated liver enzymes or creatinine may suggest organ injury, but standard clinical references emphasize providers interpret CMP with symptoms, history, medicines, and additional testing.
What can falsely affect CMP results?
Hemolysis may falsely elevate potassium; non-fasting status affects glucose; dehydration and medicines alter electrolytes, BUN, and liver enzymes — always use the reporting laboratory reference range and clinical context.
References
References
-
U.S. National Library of Medicine. Comprehensive Metabolic Panel (CMP). MedlinePlus.https://medlineplus.gov/lab-tests/comprehensive-metabolic-panel-cmp/
-
U.S. National Library of Medicine. Basic Metabolic Panel (BMP). MedlinePlus.https://medlineplus.gov/lab-tests/basic-metabolic-panel-bmp/
-
National Institute of Diabetes and Digestive and Kidney Diseases. Chronic Kidney Disease Tests & Diagnosis. NIDDK.https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/tests-diagnosis
-
KDIGO. Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplements.https://kdigo.org/guidelines/acute-kidney-injury/
-
National Institute of Diabetes and Digestive and Kidney Diseases. Liver Disease. NIDDK.https://www.niddk.nih.gov/health-information/liver-disease
-
American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes — Classification and Diagnosis. Diabetes Care.https://diabetesjournals.org/care/issue/47/Supplement_1
-
Lewis JL; Bienstock JL; Montano ET. Overview of Electrolytes. Merck Manual Professional Edition.https://www.merckmanuals.com/professional/endocrine-and-metabolic-disorders/electrolyte-disorders/overview-of-electrolytes
-
Kwo PY; Cohen SM; Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. American Journal of Gastroenterology.https://journals.lww.com/ajg/Fulltext/2017/07000/ACG_Clinical_Guideline__Evaluation_of_Abnormal.14.aspx
Editorial Standards & Medical Review
About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on diagnostic safety, clinical interpretation, and bedside nursing judgment.
Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, diagnostic safety, and alignment with current standards for Comprehensive Metabolic Panel (CMP).
Policies: Medical Review Process · Editorial Policy · Correction Policy